CEFALY news

Cefaly® the first device of its kind to receive U.S. Food and Drug Administration (FDA) approval for the preventive treatment of migraine headaches wants all migraineurs to enjoy a safe, and migraine-free, 4th of July.

“A terrible migraine can dampen any holiday,” says Dr. Mark Harman, US Medical Director with CEFALY Technology. “We’d like any fogginess this Independence Day to be from the fireworks, not a side effect from medication.” Dr. Harman has

Renowned for helping prevent migraine attacks, a new FDA clearance paves way for more Cefaly devices that can now stop a migraine in progress and prevent a future episode too.

CEFALY Technology announces today the release of two new U.S. Food and Drug Administration (FDA)-cleared migraine treatment devices. Cefaly®, already the first FDA-approved external trigeminal nerve stimulation (e-TNS) device for the prevention of migraine attacks,